Weidong G. Lai

Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng et al. · Cancer Discovery · 2018 · 112 citations

Medicine, Oncology, Pharmacology +17

Contribution of Metabolites to P450 Inhibition–Based Drug–Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group

Hongbin Yu, Suresh K. Balani, Wei‐Chao Chen et al. · Drug Metabolism and Disposition · 2015 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs

Maiko Nomoto, Cynthia Zamora, Edgar Schuck et al. · British Journal of Clinical Pharmacology · 2018 · 26 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C9*3 variants

Y. Amy Siu, Ming‐Hong Hao, Vaishali Dixit et al. · Drug Metabolism and Pharmacokinetics · 2018 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +8

Investigation of the Metabolism of Rufinamide and Its Interaction with Valproate

Eric T. Williams, J. Eric Carlson, Weidong G. Lai et al. · Drug Metabolism Letters · 2011 · 24 citations

Medicine, Biochemistry, Pharmacology +17